Methods and systems for monitoring and determining antimicrobial resistance and antimicrobial treatment using genomic subtype information are provided. Various embodiments utilize molecular epidemiology and next-generation sequencing technologies (NGS) to monitor multi-drug resistant pathogens and provide early insight into emergent microbial threats.